Julien L. Pham, MD, MPH is a highly accomplished nephrologist, entrepreneur, and investor with a keen interest in innovation and the impact of technological advancements on medicine. He has a proven track record of founding, managing, and investing in numerous startups across the healthcare industry. Most recently, he was the President & Chief Operating Officer of a publicly-traded biotech company that is at the forefront of developing effective gene therapy for cancer. Prior to this, he founded RubiconMD, a Health IT startup that aimed to prioritize access to specialists for primary care communities. He also founded RHINNO, a lean platform for reciprocal innovation in the healthcare IT field. He has extensive experience in clinical translational research in nephrology, in particular, vascular biology, and dialysis vascular access dysfunction. Dr. Pham has studied MPH in Clinical Effectiveness from Harvard T.H. Chan School of Public Health, MD in Medicine from University of Washington - School of Medicine, and BS in Cell and Molecular Biology; Medical History & Ethics (minor) from University of Washington.